Navigation Links
Canadian researchers first worldwide to generate pluripotent stem cells from horses
Date:2/27/2011

This release is available in French.

In a world first, pluripotent stem cells have been generated from horses by a team of researchers led by Dr. Andras Nagy at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital and Dr. Lawrence Smith at the University of Montreal's Faculty of Veterinary Science. The findings will help enable new stem-cell based regenerative therapies in veterinary medicine, and because horses' muscle and tendon systems are similar to our own, aid the development of preclinical models leading to human applications. The study was published in the February 28 issue of the leading journal Stem Cell Reviews and Reports.

These induced pluripotent stem (iPS) cells can develop into most other cell types and are a source of great hope for use in regenerative medicine and the development of new drugs to prevent and treat various illnesses. One aspect of regenerative medicine is the process of creating living, functional tissues to repair or replace tissue or organ function lost due to damage or disease. "To date, iPS cells have been established from several species, but our study is the first to report the derivation of these changeable cells from horses," Dr. Smith explained.

The research represents a breakthrough for both human and animal health alike. "Equine iPS cells bring new therapeutic potential to the veterinary field, and open up the opportunity to validate stem-cell based therapies before clinical studies in humans," Dr. Nagy said. "As well, stem-cell based studies using the horse as a model more closely replicate human illnesses, when compared with studies in mice."

After two months of reprogramming equine somatic cells, the resulting iPS cell lines expressed hallmark markers of pluripotency, contained a correct set of horse chromosomes, and were able to form a full spectrum of cell types
'/>"/>

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Page: 1 2

Related biology news :

1. First images from medical beamline at Canadian Light Source
2. Canadian scientist mines drugs database for new diabetes treatment
3. Fossil evidence of missing link in the origin of seals, sea lions, walruses found in Canadian Arctic
4. Canadian biomedical engineering pioneer receives international award
5. Canadian-based UN coral reef expert honored at world meeting in Australia
6. University of Saskatchewan and Canadian Synchrotron researchers shed light on esophageal disease
7. Canadian synchrotron conference sheds light on new biomedical research
8. Canadian excellence strengthened by extensive adoption of open access
9. Canadian researchers set to study impact of nanomaterials on aquatic ecosystems
10. Canadian scientists identify gene that makes water striders glide across water
11. Canadian research breakthrough holds promise for development of effective cancer therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... from the University of Tbingen, Arizona State University, the ... Public Health Institute (Swiss TPH) isolated Mycobacterium pinnipedii ... least 1000 years old. The pathogen is a relative ... occasionally causes disease in humans today. These researchers assume ... Peruvian coast. "The link to sea lions was unexpected" ...
(Date:8/20/2014)... that acral melanomas the rare type of skin cancer ... distinct from other more common types of skin cancer, according ... Pigment Cell & Melanoma Research . , Acral melanoma ... the feet, nail-beds and other hairless parts of the skin. ... by UV damage from the sun. , The team, from ...
(Date:8/20/2014)... and plastic bags could one day be made out ... scientists are now reporting. The novel process they developed ... with its agricultural and plastic waste problems, appear in ... Ilker S. Bayer and colleagues at the Italian Institute ... growing. In 2012, its production reached 288 million tons ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2
... , Cincinnati, (OH) - The International Rett Syndrome Foundation (IRSF) ... 18 new grants designed to study a variety of diverse ... and outcome measures for Rett syndrome. IRSF is the ... Rett syndrome research with the cumulative total of research spending ...
... German-based project is setting out to rescue biodiversity data at ... institutional databases, are kept in outdated digital storage systems, or ... Botanic Garden and Botanical Museum Berlin-Dahlem, provides a good example ... data. This is one of a set of data ...
... that is associated with the spread of cancer has won ... one of this year,s Kaye Innovation Awards at the university. ... of Prof. Chaim Gilon and Prof. Alexander Levitzki at the ... B (PKB, also called Akt). Since the activation of PKB ...
Cached Biology News:IRSF awards over $1.5 million for basic and translational research for Rett syndrome 2IRSF awards over $1.5 million for basic and translational research for Rett syndrome 3German research team targets 'at risk' data on biodiversity 2German research team targets 'at risk' data on biodiversity 3
(Date:8/20/2014)... The 6th Annual Arrowhead Personalized ... October 29-30 in San Francisco, CA. This year’s conference ... researchers and clinicians focused on addressing and solving the ... the twelve years since the sequencing of the human ... with pharmacogenetic information in the label and molecular diagnostics ...
(Date:8/20/2014)... your ear could improve the health of your heart, ... of Leeds used a standard TENS machine like those ... to the tragus, the small raised flap at the ... ear canal. , The stimulation changed the influence of ... nervous signals that can drive failing hearts too hard. ...
(Date:8/19/2014)... 2014 One of the major ... an inadequate vascular supply. Nutrient and gas transport ... is critical for successful regeneration and integration into ... deficiencies in vascularization and promote angiogenesis in a ... scaffold design and architecture, and enhancing scaffolds with ...
(Date:8/19/2014)... Pa. , Aug. 19, 2014 A ... has been nominated for a Centers for Disease Control ... addressing a major public health concern. ... System, is one of a team of researchers nominated ... Charles C. Shepard Science Award for Data Methods and ...
Breaking Biology Technology:6th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2'Tickling' your ear could be good for your heart 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3
... Jan. 9, 2012 Reportlinker.com announces ... is available in its catalogue: , ... Transplantation, Cord Blood Banking and Drug ... There is great interest ...
... Sequenom, Inc. (NASDAQ: SQNM ), a life ... of the Company,s 2011 performance and accomplishments, as well as ... Initial 2011 Performance Results ... for 2011 (unaudited). , Over 21,000 total prenatal and ...
... today that it has secured $47.5 million in Series ... financing along with existing investors OrbiMed Advisors, New Enterprise ... financing, Josh Bilenker, M.D., Partner at Aisling Capital, will ... round will support commercialization of the company,s Atlas™ System ...
Cached Biology Technology:Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 2Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 3Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 4Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 5Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 6Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 2Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 3Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 4Roka Bioscience Secures $47.5 Million in Series D Financing 2